Remdesivir: What is it and why is it being black marketed? All you need to know
Op IndiaIn the last month, India went from reporting around 25,000+ Covid-19 cases to 1,85,000+ cases. In May 2020, the US Food and Drug Administration issued an emergency use authorisation for Remdesivir for the treatment of Covid-19 in adults and children hospitalised with severe disease. It may also help to conserve scarce health care resources, such as ventilators, during this pandemic.” However, the study added that the drug alone was not sufficient treatment for all patients. WHO had warned against usage of Remdesivir In November 2020, World Health Organization recommended against the use of Remdesivir in Covid-19 patients stating that there was no evidence that the drug can improve survival. She said, “there are smaller studies that have shown, in some small subgroups, perhaps some marginal benefits, like some patients who need low flow oxygen, the NIH trial showed that there was perhaps a marginal mortality benefit, but that is a very small subgroup of patients.” As WHO is still waiting for the results of more studies, it is not recommending the use of Remdesivir in Covid-19 patients.